探析肾脏疾病患者应用生化免疫检查的临床有效性
详细信息    查看官网全文
摘要
目的:探析采用生化免疫检查进行肾脏疾病诊断的临床有效性及可行性。方法:选择2014年1月~2016年6月我院收治的80例肾脏疾病患者,随机分为对照组(免疫检查组)与观察组(生化免疫检查组),每组各40例,对两组实验室指标及肾脏疾病检出率进行对比分析。结果:观察组24h尿蛋白量、肌酐指标检测结果与对照组比较存在显著统计学差异(P<0.05),有39例患者尿微量白蛋白与尿肌酐比值>3,被诊断为肾脏疾病,检出率为97.5%,明显高于对照组检出率,组间比较存在显著统计学差异(P<0.05)。结论:应用生化免疫检查可显著提高肾脏疾病检出率,从而为临床治疗提供可靠依据,值得临床推广。
Objective:To explore the clinical efficacy and feasibility of biochemical immunoassay for renal disease diagnosis.Methods:Eighty patients with kidney disease were enrolled in our hospital from January 2014 to June 2016.They were randomly divided into control group(immunoassay group) and observation group(biochemical immunoassay group),40 cases in each group,Group laboratory indicators and kidney disease detection rate were compared and analyzed.Results:There was significant difference between 24 h urinary protein and creatinine index in the observation group(P < 0.05).There were 39 cases of urinary microalbumin and urinary creatinine ratio > 3,and was diagnosed as renal disease.The rate of detection was 97.5%,which was significantly higher than that of the control group(P < 0.05).Conclusion:The application of biochemical immunoassay can significandy improve the detection rate of kidney disease,so as to provide a reliable basis for clinical treatment,worthy of clinical promotion.
引文
[1]张淑华.探析肾脏疾病患者应用生化免疫检查的临床有效性[J].中国保健营养,2016,26(5):107-109.
    [2]季亚萍.尿蛋白定量、血红蛋白计数、血清肌酐联合AT-Ⅲ生化免疫检查在肾脏疾病中的诊治研究[J].中国实用医药,2016,11(30):45-46.
    [3]王清华.生化检查与免疫检查在肾脏疾病临床诊治中的应用价值[J].中国医学创新,2015,12(32):124-125.
    [4]刘凡,孔薇.中医药调控中心粒细胞明胶酶相关脂质运载蛋白在肾脏病中作用的研究进展[J].中国中医急症,2015,24(11):1983-1985.
    [5]王世农.血清胱抑素-C、血清肌酐与尿微量白蛋白联合检测在慢性肾病临床诊断中意义[J].中国实验诊断学,2013,17(3):545-546.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700